WO2005019159A1 - 光学活性α−アミノオキシケトン誘導体及びその製造方法 - Google Patents
光学活性α−アミノオキシケトン誘導体及びその製造方法 Download PDFInfo
- Publication number
- WO2005019159A1 WO2005019159A1 PCT/JP2004/012008 JP2004012008W WO2005019159A1 WO 2005019159 A1 WO2005019159 A1 WO 2005019159A1 JP 2004012008 W JP2004012008 W JP 2004012008W WO 2005019159 A1 WO2005019159 A1 WO 2005019159A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- general formula
- mmol
- proline
- substituent
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title abstract description 23
- 150000002576 ketones Chemical class 0.000 claims abstract description 30
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 22
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 21
- 150000003147 proline derivatives Chemical class 0.000 claims abstract description 21
- 125000003118 aryl group Chemical group 0.000 claims abstract description 18
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 16
- 150000002832 nitroso derivatives Chemical class 0.000 claims abstract description 16
- 125000000304 alkynyl group Chemical group 0.000 claims abstract description 14
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 claims abstract description 12
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 9
- 125000004104 aryloxy group Chemical group 0.000 claims abstract description 8
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract description 8
- 125000004423 acyloxy group Chemical group 0.000 claims abstract 2
- 238000006243 chemical reaction Methods 0.000 claims description 41
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 38
- 125000001424 substituent group Chemical group 0.000 claims description 35
- XEVRDFDBXJMZFG-UHFFFAOYSA-N carbonyl dihydrazine Chemical class NNC(=O)NN XEVRDFDBXJMZFG-UHFFFAOYSA-N 0.000 claims description 16
- 239000000126 substance Substances 0.000 claims description 5
- HDSBLKAEYBOAAX-UHFFFAOYSA-N dihydrazinyl carbonate Chemical class NNOC(=O)ONN HDSBLKAEYBOAAX-UHFFFAOYSA-N 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 104
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 81
- 239000000243 solution Substances 0.000 description 64
- 238000005481 NMR spectroscopy Methods 0.000 description 60
- 238000004128 high performance liquid chromatography Methods 0.000 description 60
- 229960002429 proline Drugs 0.000 description 52
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 46
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 34
- 229960004592 isopropanol Drugs 0.000 description 32
- 238000001914 filtration Methods 0.000 description 31
- 230000003287 optical effect Effects 0.000 description 31
- 239000002904 solvent Substances 0.000 description 31
- 239000012074 organic phase Substances 0.000 description 28
- NLRKCXQQSUWLCH-UHFFFAOYSA-N nitrosobenzene Chemical compound O=NC1=CC=CC=C1 NLRKCXQQSUWLCH-UHFFFAOYSA-N 0.000 description 27
- 238000004440 column chromatography Methods 0.000 description 26
- 239000008363 phosphate buffer Substances 0.000 description 25
- 238000003756 stirring Methods 0.000 description 25
- -1 n-octyl Chemical group 0.000 description 24
- 239000005416 organic matter Substances 0.000 description 19
- 239000012267 brine Substances 0.000 description 17
- 238000000746 purification Methods 0.000 description 17
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 17
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 16
- 125000004432 carbon atom Chemical group C* 0.000 description 13
- 239000003054 catalyst Substances 0.000 description 13
- 239000000203 mixture Substances 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 241001274216 Naso Species 0.000 description 7
- 229930182821 L-proline Natural products 0.000 description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
- YKFKEYKJGVSEIX-UHFFFAOYSA-N cyclohexanone, 4-(1,1-dimethylethyl)- Chemical compound CC(C)(C)C1CCC(=O)CC1 YKFKEYKJGVSEIX-UHFFFAOYSA-N 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- YGCZTXZTJXYWCO-UHFFFAOYSA-N 3-phenylpropanal Chemical compound O=CCCC1=CC=CC=C1 YGCZTXZTJXYWCO-UHFFFAOYSA-N 0.000 description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- QAVUAIFIABYJGI-UHFFFAOYSA-N diamino carbonate Chemical class NOC(=O)ON QAVUAIFIABYJGI-UHFFFAOYSA-N 0.000 description 4
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 4
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 4
- KNSPBSQWRKKAPI-UHFFFAOYSA-N 2,2-dimethylcyclohexan-1-one Chemical compound CC1(C)CCCCC1=O KNSPBSQWRKKAPI-UHFFFAOYSA-N 0.000 description 3
- PXQMSTLNSHMSJB-UHFFFAOYSA-N 4,4-dimethylcyclohexan-1-one Chemical compound CC1(C)CCC(=O)CC1 PXQMSTLNSHMSJB-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- ONIBWKKTOPOVIA-SCSAIBSYSA-N D-Proline Chemical compound OC(=O)[C@H]1CCCN1 ONIBWKKTOPOVIA-SCSAIBSYSA-N 0.000 description 3
- 229930182820 D-proline Natural products 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- CGZZMOTZOONQIA-UHFFFAOYSA-N cycloheptanone Chemical compound O=C1CCCCCC1 CGZZMOTZOONQIA-UHFFFAOYSA-N 0.000 description 3
- 125000003493 decenyl group Chemical group [H]C([*])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 3
- COCAUCFPFHUGAA-MGNBDDOMSA-N n-[3-[(1s,7s)-5-amino-4-thia-6-azabicyclo[5.1.0]oct-5-en-7-yl]-4-fluorophenyl]-5-chloropyridine-2-carboxamide Chemical compound C=1C=C(F)C([C@@]23N=C(SCC[C@@H]2C3)N)=CC=1NC(=O)C1=CC=C(Cl)C=N1 COCAUCFPFHUGAA-MGNBDDOMSA-N 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- OVRJVKCZJCNSOW-UHFFFAOYSA-N thian-4-one Chemical compound O=C1CCSCC1 OVRJVKCZJCNSOW-UHFFFAOYSA-N 0.000 description 3
- WKKAAHXQYBOJKV-CYBMUJFWSA-N (2r)-2-anilinooxy-4,4-dimethylcyclohexan-1-one Chemical compound C1C(C)(C)CCC(=O)[C@@H]1ONC1=CC=CC=C1 WKKAAHXQYBOJKV-CYBMUJFWSA-N 0.000 description 2
- QFHNHNNRQVLGAS-GFCCVEGCSA-N (2r)-2-anilinooxycyclohexan-1-one Chemical compound O=C1CCCC[C@H]1ONC1=CC=CC=C1 QFHNHNNRQVLGAS-GFCCVEGCSA-N 0.000 description 2
- MSANHHHQJYQEOK-KNVOCYPGSA-N (3r,5s)-3,5-dimethylcyclohexan-1-one Chemical compound C[C@H]1C[C@@H](C)CC(=O)C1 MSANHHHQJYQEOK-KNVOCYPGSA-N 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 2
- CXWGKAYMVASWDQ-UHFFFAOYSA-N 1,2-dithiane Chemical compound C1CCSSC1 CXWGKAYMVASWDQ-UHFFFAOYSA-N 0.000 description 2
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- ZVJQBBYAVPAFLX-UHFFFAOYSA-N 3,3-dimethylcyclohexan-1-one Chemical compound CC1(C)CCCC(=O)C1 ZVJQBBYAVPAFLX-UHFFFAOYSA-N 0.000 description 2
- YGHRJJRRZDOVPD-UHFFFAOYSA-N 3-methylbutanal Chemical compound CC(C)CC=O YGHRJJRRZDOVPD-UHFFFAOYSA-N 0.000 description 2
- UJBOOUHRTQVGRU-UHFFFAOYSA-N 3-methylcyclohexan-1-one Chemical compound CC1CCCC(=O)C1 UJBOOUHRTQVGRU-UHFFFAOYSA-N 0.000 description 2
- CJAUDSQXFVZPTO-UHFFFAOYSA-N 3-phenylcyclohexan-1-one Chemical compound C1C(=O)CCCC1C1=CC=CC=C1 CJAUDSQXFVZPTO-UHFFFAOYSA-N 0.000 description 2
- QCWGWVNDCMJXAK-UHFFFAOYSA-N 4-[tert-butyl(diphenyl)silyl]oxycyclohexan-1-one Chemical compound C=1C=CC=CC=1[Si](C=1C=CC=CC=1)(C(C)(C)C)OC1CCC(=O)CC1 QCWGWVNDCMJXAK-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
- 239000003905 agrochemical Substances 0.000 description 2
- NBZANZVJRKXVBH-GYDPHNCVSA-N alpha-Cryptoxanthin Natural products O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/[C@H]2C(C)=CCCC2(C)C)\C)/C)\C)/C)=C(C)C1 NBZANZVJRKXVBH-GYDPHNCVSA-N 0.000 description 2
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 description 2
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 150000001879 copper Chemical class 0.000 description 2
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- LOZWAPSEEHRYPG-UHFFFAOYSA-N dithiane Natural products C1CSCCS1 LOZWAPSEEHRYPG-UHFFFAOYSA-N 0.000 description 2
- 125000005066 dodecenyl group Chemical group C(=CCCCCCCCCCC)* 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000006038 hexenyl group Chemical group 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- GVYLCNUFSHDAAW-UHFFFAOYSA-N mirex Chemical compound ClC12C(Cl)(Cl)C3(Cl)C4(Cl)C1(Cl)C1(Cl)C2(Cl)C3(Cl)C4(Cl)C1(Cl)Cl GVYLCNUFSHDAAW-UHFFFAOYSA-N 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 2
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000005064 octadecenyl group Chemical group C(=CCCCCCCCCCCCCCCCC)* 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- JMJRYTGVHCAYCT-UHFFFAOYSA-N oxan-4-one Chemical compound O=C1CCOCC1 JMJRYTGVHCAYCT-UHFFFAOYSA-N 0.000 description 2
- ATYBXHSAIOKLMG-UHFFFAOYSA-N oxepin Chemical compound O1C=CC=CC=C1 ATYBXHSAIOKLMG-UHFFFAOYSA-N 0.000 description 2
- 125000002958 pentadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229940100595 phenylacetaldehyde Drugs 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000005063 tetradecenyl group Chemical group C(=CCCCCCCCCCCCC)* 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 229930192474 thiophene Natural products 0.000 description 2
- 150000003852 triazoles Chemical class 0.000 description 2
- 125000005040 tridecenyl group Chemical group C(=CCCCCCCCCCCC)* 0.000 description 2
- GZVXSRSFODKRJN-AWEZNQCLSA-N (2r)-2-anilinooxy-2-phenylethanol Chemical compound O([C@@H](CO)C=1C=CC=CC=1)NC1=CC=CC=C1 GZVXSRSFODKRJN-AWEZNQCLSA-N 0.000 description 1
- DKFDBDVVGNRBAX-NSHDSACASA-N (2r)-2-anilinooxy-3-methylbutan-1-ol Chemical compound CC(C)[C@H](CO)ONC1=CC=CC=C1 DKFDBDVVGNRBAX-NSHDSACASA-N 0.000 description 1
- AGANEPCIYZTRED-CYBMUJFWSA-N (2r)-2-anilinooxycycloheptan-1-one Chemical compound O=C1CCCCC[C@H]1ONC1=CC=CC=C1 AGANEPCIYZTRED-CYBMUJFWSA-N 0.000 description 1
- WYFXQBZESYRHQN-LLVKDONJSA-N (2r)-2-anilinooxypentan-1-ol Chemical compound CCC[C@H](CO)ONC1=CC=CC=C1 WYFXQBZESYRHQN-LLVKDONJSA-N 0.000 description 1
- LFIGVWCABSLPQY-MRVPVSSYSA-N (2r)-2-anilinooxypropan-1-ol Chemical compound OC[C@@H](C)ONC1=CC=CC=C1 LFIGVWCABSLPQY-MRVPVSSYSA-N 0.000 description 1
- NCGCXDNPDIRTNK-IUODEOHRSA-N (2r,4r)-2-anilinooxy-4-tert-butylcyclohexan-1-one Chemical compound C1[C@H](C(C)(C)C)CCC(=O)[C@@H]1ONC1=CC=CC=C1 NCGCXDNPDIRTNK-IUODEOHRSA-N 0.000 description 1
- MQHRUOMPTQDZRN-PZJWPPBQSA-N (2r,5s)-2-anilinooxy-5-(4-tert-butylphenyl)sulfanylcyclohexan-1-one Chemical compound C1=CC(C(C)(C)C)=CC=C1S[C@@H]1CC(=O)[C@H](ONC=2C=CC=CC=2)CC1 MQHRUOMPTQDZRN-PZJWPPBQSA-N 0.000 description 1
- WKKAAHXQYBOJKV-ZDUSSCGKSA-N (2s)-2-anilinooxy-4,4-dimethylcyclohexan-1-one Chemical compound C1C(C)(C)CCC(=O)[C@H]1ONC1=CC=CC=C1 WKKAAHXQYBOJKV-ZDUSSCGKSA-N 0.000 description 1
- ASGJKCOINAVPRV-SFTDATJTSA-N (2s,3s)-2-anilinooxy-3-(4-tert-butylphenyl)sulfanylcyclohexan-1-one Chemical compound C1=CC(C(C)(C)C)=CC=C1S[C@@H]1[C@@H](ONC=2C=CC=CC=2)C(=O)CCC1 ASGJKCOINAVPRV-SFTDATJTSA-N 0.000 description 1
- LSQFVPQVQPGESM-LLVKDONJSA-N (3r)-3-anilinooxyoxan-4-one Chemical compound O=C1CCOC[C@H]1ONC1=CC=CC=C1 LSQFVPQVQPGESM-LLVKDONJSA-N 0.000 description 1
- IBTSIFIGTARYRB-UHFFFAOYSA-N 1,3-dihydroxyurea Chemical compound ONC(=O)NO IBTSIFIGTARYRB-UHFFFAOYSA-N 0.000 description 1
- VKRKCBWIVLSRBJ-UHFFFAOYSA-N 1,4-dioxaspiro[4.5]decan-8-one Chemical compound C1CC(=O)CCC21OCCO2 VKRKCBWIVLSRBJ-UHFFFAOYSA-N 0.000 description 1
- HUUPVABNAQUEJW-UHFFFAOYSA-N 1-methylpiperidin-4-one Chemical compound CN1CCC(=O)CC1 HUUPVABNAQUEJW-UHFFFAOYSA-N 0.000 description 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- SKMXAPKCJVVDRT-UHFFFAOYSA-N 2-[tert-butyl(diphenyl)silyl]oxycyclohexan-1-one Chemical compound [Si](C1=CC=CC=C1)(C1=CC=CC=C1)(C(C)(C)C)OC1C(CCCC1)=O SKMXAPKCJVVDRT-UHFFFAOYSA-N 0.000 description 1
- PGYAIVJHGZHBIE-UHFFFAOYSA-N 3-(4-tert-butylphenyl)sulfanylcyclohexan-1-one Chemical compound C1=CC(C(C)(C)C)=CC=C1SC1CC(=O)CCC1 PGYAIVJHGZHBIE-UHFFFAOYSA-N 0.000 description 1
- DVNMWQDUUKBGJR-UHFFFAOYSA-N 4,4-diethoxycyclohexan-1-one Chemical compound CCOC1(OCC)CCC(=O)CC1 DVNMWQDUUKBGJR-UHFFFAOYSA-N 0.000 description 1
- UOJCLZFJKRTXGV-UHFFFAOYSA-N 4,4-dimethoxycyclohexan-1-one Chemical compound COC1(OC)CCC(=O)CC1 UOJCLZFJKRTXGV-UHFFFAOYSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N 4-(hydroxymethyl)oxolane-2,3,4-triol Chemical compound OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- ZCYDQSUQFINRLP-UHFFFAOYSA-N AD-I Natural products CC=C(C)/C(=O)OC1C(OC(=O)CC(C)C)c2cc3C=CC(=O)Oc3cc2OC1(C)C ZCYDQSUQFINRLP-UHFFFAOYSA-N 0.000 description 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 1
- ORILYTVJVMAKLC-UHFFFAOYSA-N Adamantane Natural products C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 1
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- YPWFISCTZQNZAU-UHFFFAOYSA-N Thiane Chemical compound C1CCSCC1 YPWFISCTZQNZAU-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical group 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000006256 asymmetric dihydroxylation reaction Methods 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- GPTJTTCOVDDHER-UHFFFAOYSA-N cyclononane Chemical compound C1CCCCCCCC1 GPTJTTCOVDDHER-UHFFFAOYSA-N 0.000 description 1
- WJTCGQSWYFHTAC-UHFFFAOYSA-N cyclooctane Chemical compound C1CCCCCCC1 WJTCGQSWYFHTAC-UHFFFAOYSA-N 0.000 description 1
- 239000004914 cyclooctane Substances 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000011982 enantioselective catalyst Substances 0.000 description 1
- 238000006735 epoxidation reaction Methods 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005186 naphthyloxy group Chemical group C1(=CC=CC2=CC=CC=C12)O* 0.000 description 1
- 125000001196 nonadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005187 nonenyl group Chemical group C(=CCCCCCCC)* 0.000 description 1
- SJGALSBBFTYSBA-UHFFFAOYSA-N oxaziridine Chemical compound C1NO1 SJGALSBBFTYSBA-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- QRUBYZBWAOOHSV-UHFFFAOYSA-M silver trifluoromethanesulfonate Chemical compound [Ag+].[O-]S(=O)(=O)C(F)(F)F QRUBYZBWAOOHSV-UHFFFAOYSA-M 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- XITYWQKWNJFZEG-UHFFFAOYSA-J tetraphenoxystannane Chemical compound [Sn+4].[O-]C1=CC=CC=C1.[O-]C1=CC=CC=C1.[O-]C1=CC=CC=C1.[O-]C1=CC=CC=C1 XITYWQKWNJFZEG-UHFFFAOYSA-J 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- HTSABYAWKQAHBT-UHFFFAOYSA-N trans 3-methylcyclohexanol Natural products CC1CCCC(O)C1 HTSABYAWKQAHBT-UHFFFAOYSA-N 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229940100050 virazole Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
- C07C239/08—Hydroxylamino compounds or their ethers or esters
- C07C239/20—Hydroxylamino compounds or their ethers or esters having oxygen atoms of hydroxylamino groups etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/08—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Definitions
- the present invention relates to a para-aminooxyketone derivative which can be easily converted to a para-hydroxyketone useful for pharmaceuticals, agricultural chemicals, and the like, and a production method for obtaining the same with a high yield and a high enantioselectivity.
- Non-Patent Document 1 ⁇ -hydroxyketone has been synthesized by diastereoselective reaction or enantioselective reaction after once converting ketone to a corresponding enolate or its equivalent (see Non-Patent Document 1). .
- Examples of such a method include a method in which a ketone is introduced into a lithium enolate and then an optically active oxaziridine is allowed to act as an oxidizing agent (see Patent Documents 2 to 8).
- a method of performing asymmetric dihydroxylation after conversion to a noreether see Non-Patent Documents 9 to 10) and a method of performing asymmetric epoxidation (Non-Patent Documents 10 to 14) are known.
- Patent Document 15 Recently, a method for synthesizing monoaminooxyketones by asymmetric catalysis using nitrosobenzene using a catalytic amount of an optically active activator after converting ketones to tin enolates has been reported ( Patent Document 15).
- Non-patent document 13 Ju et al. (Zhu, Y .; Yu, Y .; Yu, H .; Shi, Y. Tetrahedron Lett. 1998, 39, 7819)
- Non-patent document 14 Adam et al.
- Non-Patent Document 15 Momiyama et al. (
- an object of the present invention is to provide a method for industrially advantageously producing an optically active ⁇ -aminooxy ketone from a ketone which does not have the above-mentioned problems, and to thereby efficiently obtain a hydroxy-ketone.
- the present invention provides the following method.
- a ketone represented by the following general formula (2) is reacted with a nitroso compound represented by the general formula (3) in the presence of a proline or a proline derivative represented by the general formula (4).
- R 1 and R 2 represent an alkyl, alkenyl or alkynyl group which may have a substituent, and R 1 and R 2 are taken together to form a ring Is also good.
- R 3 represents an aryl, heterocyclic, alkyl, alkenyl or alkynyl group which may have a substituent.
- A represents a hydrogen atom, an alkoxy group, an aryloxy group, an asinoleoxy group, or a silyloxy group which may have a substituent.
- a ketone represented by the following general formula (2) is reacted with a nitroso compound represented by the general formula (3) in the presence of a proline or a proline derivative represented by the general formula (4 ′)
- a method for producing an optically active aminoaminoketone derivative represented by the general formula (1 ′) characterized in that:
- R 1 and R 2 represent an alkyl, alkenyl or alkynyl group which may have a substituent, and R 1 and R 2 are taken together to form a ring I'm sorry.
- R 3 represents an aryl, heterocyclic, alkyl, alkenyl or alkynyl group which may have a substituent.
- A represents a hydrogen atom, an alkoxy group, an aryloxy group, an asinoleoxy group, or a silyloxy group which may have a substituent.
- one X—Y—Z— represents one selected from the following groups.
- high aminonanketone can be selectively obtained with high yield and high technical efficiency.
- proline When the catalyst is proline, proline has the feature of being inexpensive. Further, when the catalyst used is a proline derivative, particularly superproline described later, it is necessary to produce the corresponding aminoaminoketone in a short time with a high yield and high enantioselectivity as compared with proline. Can be.
- the method for producing an ⁇ -aminooxy ketone of the present invention is characterized in that the ketone represented by the general formula (2) is replaced by the nitroso compound represented by the general formula (3), ') Is characterized by reacting in the presence of a proline derivative.
- the alkyl group represented by R 1 and R 2 preferably has 20 carbon atoms, particularly preferably about 115 carbon atoms. Specifically, for example, methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, t_butyl, pentyl, hexyl, heptyl, n-octyl, 2-ethylhexyl group, tert-octyl group, nonyl group, decyl group, dodecyl group, tridecyl group, tetradecyl group, pentadecyl group, n-hexadecinole group, 2-hexynoledecinole group, heptadecinole group, octadecinole group, nonadecinole group And an icosyl group.
- the alkyl group may further have a substituent. Examples of such a substituent include the following ary
- examples of the aryl group include a phenyl and naphthyl group which may have a substituent.
- the heterocycle of the heterocyclic group includes piperidine, furan, thiophene, pyrrole, virazole, imidazole, triazole, oxazole, isoxazole, thiazole, isothiazonole, dioxolan, pyridine, pyrimidine, pyrazine, triazine, dioxane, dithiane. , Monorephorin, azepine, oxepin, chepin and the like.
- the aryl group and the heterocyclic group may further have a substituent.
- substituents include an alkyl group, an alkenyl group, a nitro group, and a halogen atom (for example, a fluorine atom, a chlorine atom, Bromine atom, iodine atom) and the like.
- the alkenyl group represented by R 1 and R 2 preferably has 2 to 20 carbon atoms, particularly preferably about 2 to 5 carbon atoms.
- the alkenyl group include a propyl group such as a vinyl group and an aryl group, a butyryl group, a pentenyl group, a hexenyl group, a heptyl group, an otatyl group, a nonenole group, a decenyl group, a decenyl group, and a dodecenyl group.
- the alkenyl group may further have a substituent. Examples of such a substituent include the above-mentioned aryl group and heterocyclic group.
- the alkynyl group preferably has 2 to 20 carbon atoms, particularly preferably 2 to 5 carbon atoms.
- R 1 and R 2 may be combined to form a ring.
- a ring examples include cyclohexane, cyclopentane, cycloheptane, cyclooctane, cyclononane, tetrahydrofuran, tetrahydropyran, piperidine, pyrrolidine, thiacyclohexane, and the like.
- These rings may further have a substituent. Examples of such a substituent include the above-mentioned alkyl group, alkenyl group, alkynyl group, aryl group, and heterocyclic group.
- ketone represented by the general formula (2) include cyclohexanone, cyclopentanone, dimethylcyclohexanone, 1,4-cyclohexanedione monoethylene ketal, tetrahydropyran-4-one, Piberidinone, 3_pentanone, tetrahydrothiopyran-4-one, 3,3-dimethylcyclohexanone, cis-3,5-dimethylcyclohexanone, 3-methylcyclohexanone, 3-phenylcyclohexanone, 4-tert -Butylcyclohexanone, 4_ (tert-butyldiphenylsiloxy) cyclohexanone, cycloheptanone, 2-butanone, 1,5-dioxaspiro [5.5] pendency-9-one, 1,5-dithiaspiro [5.5] And penta-9-one, 4,4-dimethoxycyclohexanone
- aryl group represented by R 3 a phenyl group which may have a substituent, a naphthyl group and the like are preferable.
- examples of the hetero ring of the heterocyclic group represented by R 3 include piperidine, furan, thiophene, pyrrole, pyrazole, imidazole, triazole, oxazole, isooxazole, thiazole, isothiazole, and dioxolane.
- the aryl group and the heterocyclic group may further have a substituent.
- substituents include an alkyl group, an alkenyl group, a nitro group, and a halogen atom (for example, a fluorine atom, a chlorine atom, Bromine atom, iodine atom) and the like.
- the alkyl group represented by R 3 preferably has 20 carbon atoms. Those having about 115 carbon atoms are preferred. Specifically, for example, methyl, ethyl, propynole, isopropyl, n-butyl, sec-butyl, t-butyl, pentyl, hexyl, heptyl, n-octyl, 2-ethylhexyl, tert-octyl, nonyl, decyl, dodecinole, tridecinole, tetradecinole, pentadecyl, n-hexadecyl, 2_hexynoledecinole, heptadecinole, octadecyl, nonadecyl And an icosyl group.
- the alkyl group may further have a substituent. Examples of such a substituent include the above aryl group and heterocyclic group.
- the alkenyl group represented by R 3 preferably has 2 to 20 carbon atoms, and particularly preferably has about 25 carbon atoms.
- the alkenyl group include a propyl group such as a butyl group and an aryl group, a butyryl group, a pentenyl group, a hexenyl group, a heptyl group, an otathyl group, a nonenyl group, a decenyl group, a pendecenyl group, a dodecenyl group and a tridecenyl group.
- alkenyl group may further have a substituent.
- substituents include the above-mentioned aryl group and heterocyclic group.
- the alkynyl group represented by R 3 is preferably a group having 2-20 carbon atoms, particularly preferably a group having 2-5 carbon atoms.
- nitrosobenzene is preferable.
- proline or a proline derivative represented by the general formula (4) or (4 ′) is used as the asymmetric catalyst.
- A represents a hydrogen atom, an alkoxy group, an aryloxy group, an alkoxy group, or a silyloxy group which may have a substituent.
- alkoxy group include those having 115 carbon atoms, such as a methoxy group, an ethoxy group, a propoxy group, a butoxy group, and a pentyloxy group.
- aryloxy group include a phenyloxy group, a naphthyloxy group, and the like.
- the asinoleoxy group include an acetoxy group and a benzoyloxy group.
- Examples of the substituent of the silyloxy group include an alkyl group, an aryl group, and an alkenyl group.
- A is a methoxy group, see Rhoda et al. Roda, Aldo; Cerre, Carolina; Marietta, Anna C; Cainelli, Gianfranco; Ronchi, Achille Umani; Panunzio, Mauro. Journal of Medicinal Chemistry (1996), 39 (11), 2270-6.)
- Is a benzoyloxy group see Perni, Robert et .; Britt, Shawn D .; Court, John; Courtney, Lawrence .; Deimnger, David D .;
- A is preferably a tert-butyldimethylsilyloxy group or a triisopropylsilyloxy group, particularly a tert-butyldimethylsilyloxy group (proline having this group is referred to as "super-proline” Is preferred). This is because the reaction is completed in a much shorter time and the asymmetric yield is very high, compared to the case where A is a hydrogen atom (proline). It should be noted that super phosphorus is known (H. Ohtake, Y. Imada, S-1. Murahashi, Bull. Chem. Soc. Jpn. 1999, 72, 2737.).
- a ketone represented by the following general formula (2) and proline or a proline derivative (4) [(4 ′) is assumed to contain (4 ′) since the reaction proceeds in the same manner.
- the proline or proline derivative (4) is preferably used in an amount of 0.01 to 1 equivalent to the nitroso compound (3), particularly preferably 0.1 to 0.3 equivalent.
- the organic solvents used here include DMF, DMSO, CH NO
- polar solvents such as NMP (N-methyl-pyrrolidinone), CHCN, CHC1, CHCI, etc. are preferred, but are not limited to these.
- the obtained solution of ketone and proline or proline derivative (4) may be cooled at a temperature of -50 ° C to 25 ° C, preferably -10 ° C to 10 ° C during the next reaction. It is best to keep this temperature.
- the ketone is preferably used in an amount of 115 equivalents to the nitroso compound, and particularly preferably 23 equivalents.
- the nitroso compound represented by the general formula (3) is dissolved in the above-mentioned solvent, and this is added to the ketone and the solvent of proline or the proline derivative (4).
- the time for adding the nitroso compound solution to the solution of ketone and proline or proline derivative (4) is preferably 1 minute to 24 hours, and particularly preferably 3 to 12 hours. In the case of the above-mentioned superproline, 5 minutes to 5 hours are preferable. Thereafter, stirring is carried out for 10 minutes to 1 hour while maintaining the above-mentioned temperature to obtain the aminoaminoketone.
- Example 1 (Table 2, No. 1) Cyclohexanone (1.2 mmol), L_proline (0.18 mmol) 3 ⁇ 4r Dissolve in 2.7 mL of DMF solution and cool to 0 ° C. To this solution is added dropwise a solution of nitrosobenzene (0.6 mmol) in DMF (0.9111) over 5.5 hours. After dropping, stir at the same temperature for 30 minutes. The reaction was stopped by adding a phosphate buffer, the organic matter was extracted with ethyl acetate, and the organic phase was washed with a saline solution.
- Example 8 (Table 3, entry 1, catalyst 10 mol% temperature-20 ° C)
- Extract with acidified chill wash the organic phase with brine and dry over Na 2 SO 4.
- the alcohol is quantitatively obtained with 99% ee.
- Butanal (1.8 mmol) and nitrosoben are added to a CHCN solution (3.0 mL) of proline (0.06 mmol).
- Extract with acidified chill wash the organic phase with brine and dry over Na 2 SO 4.
- the alcohol is obtained in 88% yield and 98% ee.
- Optical purity was determined by HPLC analysis using a chiral column.
- Example 10 (Table 3, entry 3, catalyst 30 mol% temperature-20 ° C)
- the 3-amino alcohol is obtained with a yield of 81% and 98% ee.
- Example 11 (Table 3, entry 4, catalyst 30 mol% temperature 0 ° C)
- Losobenzene (0.6 mmol) was added at 0 ° C, and the mixture was stirred at the same temperature for 24 hours. After i-PrOH (1.0 mL) and NaBH (3 mmol) were added and stirred for 10 minutes, the reaction was stopped by adding a phosphate buffer, and the organic matter was added.
- Example 12 (Table 3, entry 5, catalyst 30 mol% temperature 0 ° C)
- nitrosobenzene (0.6 mmol) are added at _20 ° C, and the mixture is stirred at the same temperature for 24 hours. After i-PrOH (1.0 mL) and NaBH (3 mmol) were added and stirred for 10 minutes, the reaction was stopped by adding a phosphate buffer.
- the aminooxy ketone is obtained with a yield of 60% and 99% ee.
- the diastereomer ratio is 70:30.
- the optical purity was determined by HPLC analysis using a chiral column.
- the absolute configuration is from the diol obtained by reacting NaBH on 13a (13,2 shaku, 3 shaku, 53) -1,2-bis (-bromobenzoyloxy) -3,5-dimethylcyclohexane, determined by the CD-chirality method .
- Example 18 (Table 5, entry 6) To a DMF solution (8.1 mL) of 4-tert-butylcyclohexanone (2.2 mmol) and proline (0.18 mmol) was added a DMF solution (2.7 mL) of nitrosobenzene (1.8 mmol) at 0 ° C over 32 hours. Stir at temperature for 0.5 hour. The reaction is stopped by adding a phosphate buffer, the organic matter is extracted three times with ethyl acetate, and the organic phase is washed with brine and dried over Na 2 SO 4. Na SO by filtration
- the ⁇ -aminooxy ketone is obtained in a yield of 69% and the main product in 99% ee.
- the diastereomer ratio is 67:33.
- Cyclohexanone and dimethylcyclohexanone are used as ketones as shown in the above table.
- the corresponding ⁇ -aminooxyketone derivative was obtained with high yield and high enantioselectivity.
- a ketone having an acetal moiety at the 4-position a corresponding ⁇ -aminooxyketone derivative was obtained with high yield and high enantioselectivity.
- Cyclohexanone, dimethylcyclohexanone, tetrahydro-4H-thiopyran-4-one is The product is obtained in a much shorter time than with proline.
- cyclohexanone completed a reaction that took 5.5 hours of power in 15 minutes.
- the reaction of cycloheptanone and getyl ketone was slow with proline, but by using superproline, it was possible to synthesize para-aminooxyketone with a moderate yield. All the obtained compounds have very high asymmetric yields.
- the obtained compound can be derivatized to a hydroxyketone with a divalent copper salt (N. Momiyama, H. Yamamoto, J. Am. Chem. Soc, 2003, 125, 6038.) This reaction can be applied to a method for synthesizing para-hydroxyketone having high optical purity by asymmetric catalytic reaction from ketone.
- the corresponding optically active ⁇ -aminooxy ketone can be obtained from a ketone and a nitroso compound from a ketone and a nitroso compound by using a catalytic amount of proline.
- ⁇ -hydroxyketone can be efficiently obtained.
- an ⁇ -aminooxyketone derivative can be obtained directly from a ketone which does not require conversion of the ketone to an enolate or an equivalent thereof, and the optically active substance can be obtained at low cost.
- proline which can be easily prepared, can be used as a catalyst, and a high aminooxy ketone derivative having high yield and high optical purity can be obtained.
- the catalyst is proline
- proline has the feature of being inexpensive.
- the catalyst to be used is a proline derivative, particularly superproline described later, the corresponding aminoaminoketone can be produced in a much higher yield and with a higher enantioselectivity than proline in a short time. be able to.
- aminoaminoketone derivative can be easily derivatized to a hydroxyketone with a divalent copper salt (Momiyama et al.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/569,757 US7279601B2 (en) | 2003-08-25 | 2004-08-20 | Optically active α-aminooxyketone derivatives and process for production thereof |
EP04771969A EP1661885A4 (en) | 2003-08-25 | 2004-08-20 | OPTICALLY ACTIVE ALPHA-AMINO-OXY-KETONE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003300367 | 2003-08-25 | ||
JP2003-300367 | 2003-08-25 | ||
JP2004153944 | 2004-05-24 | ||
JP2004-153944 | 2004-05-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005019159A1 true WO2005019159A1 (ja) | 2005-03-03 |
Family
ID=34220723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/012008 WO2005019159A1 (ja) | 2003-08-25 | 2004-08-20 | 光学活性α−アミノオキシケトン誘導体及びその製造方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US7279601B2 (ja) |
EP (1) | EP1661885A4 (ja) |
WO (1) | WO2005019159A1 (ja) |
-
2004
- 2004-08-20 US US10/569,757 patent/US7279601B2/en not_active Expired - Fee Related
- 2004-08-20 WO PCT/JP2004/012008 patent/WO2005019159A1/ja active Application Filing
- 2004-08-20 EP EP04771969A patent/EP1661885A4/en not_active Withdrawn
Non-Patent Citations (6)
Title |
---|
BROWN P S ET AL: "The Direct and Enantioselective Organocatalytic alpha-Oxidation of Aldehydes", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 125, no. 36, 19 August 2003 (2003-08-19), pages 10808 - 10809, XP002904211 * |
HAYASHI Y ET AL: "Direct proline catalyzed asymmetric alpha-aminooxylation of aldhytes", TETRAHEDRON LETTERS, vol. 44, no. 45, 7 October 2003 (2003-10-07), pages 8293 - 8296, XP004463846 * |
MOMIYAMA N ET AL: "Catalytic Enantioselective Synthesis of alpha-Aminooxy and alpha-Hydroxy ketone Using Nitrosobenzene", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 125, no. 20, 2003, pages 6038 - 6039, XP001160188 * |
OHTAKE H ET AL: "Regioselective Synthesis of Nitrones by Decarboxylative Oxidation of N-Alkyl-alpha-amino Acids and Application to the Synthesis of 1-Azabicyclic Alkaloids", BULL. CHEM. SOC. JPN., vol. 72, 1999, pages 2737 - 2754, XP002904212 * |
See also references of EP1661885A4 * |
ZHONG C: "A Facile and rapid Route to Highly Enantiopure 1,2-Diols by Novel Catalytic Asymmetric alpha-Aminoxylation of Aldehydes", ANGEWANDTE CHEMIE, INTERNATIONAL EDITION, vol. 42, no. 35, 12 September 2003 (2003-09-12), pages 4247 - 4250, XP002904213 * |
Also Published As
Publication number | Publication date |
---|---|
US20060293525A1 (en) | 2006-12-28 |
EP1661885A1 (en) | 2006-05-31 |
US7279601B2 (en) | 2007-10-09 |
EP1661885A4 (en) | 2006-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU226465B1 (en) | Improved process for the synthesis of protected esters of (s)-3,4-dihydroxybutyric acid | |
US20020099034A1 (en) | Process for stereoselective synthesis of prostacyclin derivatives | |
IE62940B1 (en) | Improved process for the synthesis of (4r-cis)-1, 1-dimethylethyl 6-cyanomethyl-2, 2-dimethyl-1, 3-dioxane-4-acetate | |
EP3107904B1 (en) | Substituted delta-lactones and methods of preparing same | |
KR20040073463A (ko) | 에시탈로프람의 제조 방법 | |
der Deen et al. | Enantioselective synthesis of benzylbutyrolactones from 5-hydroxyfuran-2 (5 H)-one. New chiral synthons for dibenzylbutyrolactone lignans by a chemoenzymatic route | |
IL193154A (en) | Method of producing optically active alcohol | |
JP4617114B2 (ja) | 光学活性α−アミノオキシケトン誘導体及びその製造方法 | |
WO2007054105A2 (en) | Method for the preparation of escitalopram | |
WO2005019159A1 (ja) | 光学活性α−アミノオキシケトン誘導体及びその製造方法 | |
AU2018340858A1 (en) | Chiral auxiliaries and uses thereof | |
FR2498592A1 (fr) | Procede de preparation de derives d'oxocyclopentene et nouveaux produits ainsi obtenus | |
Ito et al. | Enantioselective total synthesis of both diastereomers of preclavulone-A methyl ester | |
Lattanzi et al. | Diastereoselective synthesis of enantiopure 5-[2-(alkoxyalkyl)-1-(hydroperoxypropyl)]-3-alkoxycarbonyl-2-alkyl furans | |
JP4741199B2 (ja) | シン−α−アルキル−β−アミノカルボニル化合物の製造方法 | |
JP6979193B2 (ja) | α,β−不飽和−γ−ラクトン誘導体の合成方法 | |
JP5082091B2 (ja) | オキサゾリン化合物の製法 | |
KR100614546B1 (ko) | 입체선택성이 높은 테트라하이드로퓨란 고리화합물과 이의제조방법 | |
JP4661272B2 (ja) | キラルな4−メチル−4−[(アリールカルボオキシ)エチル]−オキセタン−2−オンおよびキラルメバロノラクトンの製造方法 | |
KR101071440B1 (ko) | β-락탐 화합물의 제조에서의 폴리-3-히드록시부티레이트의용도 | |
McIntosh et al. | Synthesis of a new ketone and alcohol with C2 symmetry;(S, S, S, S) tricyclo [6.3. 0.03, 7] undecan-2-onela and (S, S, S, S) tricyclo [6.3. 0.03, 7] undecan-2-ollb | |
Brandänge et al. | A Concise Synthesis of (2S, 5fî)-2-Methyl-5-hexanolide | |
JP2005075734A (ja) | 光学活性ホモクエン酸の製法 | |
JP2946423B2 (ja) | アファノルフィンの製造法およびその中間体 | |
EP1398312A1 (en) | Beta-substituted-gamma-butyrolactones and a process for preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006293525 Country of ref document: US Ref document number: 10569757 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004771969 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004771969 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10569757 Country of ref document: US |